136 related articles for article (PubMed ID: 1871787)
1. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin.
Kahan BD; Chang JY; Sehgal SN
Transplantation; 1991 Aug; 52(2):185-91. PubMed ID: 1871787
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of rapamycin: a new immunosuppressive agent.
Chang JY; Sehgal SN
Br J Rheumatol; 1991; 30 Suppl 2():62-5. PubMed ID: 1993260
[No Abstract] [Full Text] [Related]
3. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination.
Kahan BD; Tejpal N; Gibbons-Stubbers S; Tu Y; Wang M; Stepkowski S; Chou TC
Transplantation; 1993 Apr; 55(4):894-900. PubMed ID: 8475566
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A, FK506, rapamycin: the use of a quantitative analytic tool to discriminate immunosuppressive drug interactions.
Kahan BD
J Am Soc Nephrol; 1992 Jun; 2(12 Suppl):S222-7. PubMed ID: 1379841
[TBL] [Abstract][Full Text] [Related]
5. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.
Davies CB; Madden RL; Alexander JW; Cofer BR; Fisher RA; Anderson P
Transplantation; 1993 May; 55(5):1107-12. PubMed ID: 8497890
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
Martin DF; DeBarge LR; Nussenblatt RB; Chan CC; Roberge FG
J Immunol; 1995 Jan; 154(2):922-7. PubMed ID: 7814893
[TBL] [Abstract][Full Text] [Related]
7. Effects of rapamycin in experimental organ allografting.
Ochiai T; Gunji Y; Nagata M; Komori A; Asano T; Isono K
Transplantation; 1993 Jul; 56(1):15-9. PubMed ID: 8333037
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine and rapamycin affect protein kinase C induction of the intracellular activation signal, activator of DNA replication.
Kimball PM; Kerman RK; Van Buren CT; Lewis RM; Katz S; Kahan BD
Transplantation; 1993 May; 55(5):1128-32. PubMed ID: 8497893
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro.
Kahan BD; Gibbons S; Tejpal N; Stepkowski SM; Chou TC
Transplantation; 1991 Jan; 51(1):232-9. PubMed ID: 1987692
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus, a new, potent immunosuppressive agent.
Kelly PA; Gruber SA; Behbod F; Kahan BD
Pharmacotherapy; 1997; 17(6):1148-56. PubMed ID: 9399599
[TBL] [Abstract][Full Text] [Related]
11. Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.
Sehgal SN
Ther Drug Monit; 1995 Dec; 17(6):660-5. PubMed ID: 8588237
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of rapamycin, FK 506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the rat.
Thomson AW; Propper DJ; Woo J; Whiting PH; Milton JI; Macleod AM
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):355-69. PubMed ID: 7693791
[TBL] [Abstract][Full Text] [Related]
13. Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin).
High KP; Washburn RG
J Infect Dis; 1997 Jan; 175(1):222-5. PubMed ID: 8985226
[TBL] [Abstract][Full Text] [Related]
14. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
[TBL] [Abstract][Full Text] [Related]
15. The effect of rapamycin on c-jun expression in human lymphocytes.
Shan X; Luo H; Chen H; Daloze P; St-Louis G; Wu J
Clin Immunol Immunopathol; 1993 Dec; 69(3):314-7. PubMed ID: 8242902
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus in transplantation.
Stepkowski SM; Tian L; Wang ME; Qu X; Napoli K; Kahan BD
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):383-90. PubMed ID: 9437494
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin, a potential disease-modifying antiarthritic drug.
Carlson RP; Hartman DA; Tomchek LA; Walter TL; Lugay JR; Calhoun W; Sehgal SN; Chang JY
J Pharmacol Exp Ther; 1993 Aug; 266(2):1125-38. PubMed ID: 8355184
[TBL] [Abstract][Full Text] [Related]
18. New immunosuppressive drugs: needs in and applications to pediatric transplantation.
Kahan BD
Eur J Pediatr; 1992; 151 Suppl 1():S9-12. PubMed ID: 1345112
[TBL] [Abstract][Full Text] [Related]
19. Effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat.
Damoiseaux JG; Beijleveld LJ; Schuurman HJ; van Breda Vriesman PJ
Transplantation; 1996 Oct; 62(7):994-1001. PubMed ID: 8878395
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
